3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Oxaliplatin
3
Cisplatin
3
pembrolizumab
2
Leucovorin
2
Irinotecan
2
Gemcitabine
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Carboplatin
2
umbralisib
1
sodium thiosulfate
1
motexafin lutetium
1
montanide ISA 51
1
entinostat
1
ciforadenant
1
cediranib
1
X-Rays
1
Thalidomide
1
Standard of Care
1
Specimen Handling
1
Serotonin Plasma Membrane Transport Proteins
1
Ritonavir
1
Radiotherapy
1
Radiosurgery
1
Radionuclide Imaging
1
Quality of Life
1
Psychology, Positive
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Radionuclide Imaging
×
Sarcoma
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled